Sign Up
OverviewAPI
The cancer molecular diagnostics market is experiencing a post-pandemic resurgence, witnessing growth across all segments. Major companies like Grail and Quest Diagnostics have recently secured substantial funding, with over 120 companies profiled in the report. On the other hand, the biotechnology sector's licensing deals from 2019 to 2024 are analyzed comprehensively, highlighting key players and trends.

Ask a question